Enzo Biochem (NYSE: ENZ) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $18.16 million versus the consensus estimate of $24.5 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.